154 related articles for article (PubMed ID: 31724473)
21. Clinicopathologic features of biopsied lacrimal gland masses in 95 Korean patients.
Ahn C; Kang S; Sa HS
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1527-1533. PubMed ID: 31025214
[TBL] [Abstract][Full Text] [Related]
22. The impact of IgG-4-ROD on the diagnosis of orbital tumors: A retrospective analysis.
Andron A; Hostovsky A; Nair AG; Sagiv O; Schiby G; Simon GB
Orbit; 2017 Dec; 36(6):359-364. PubMed ID: 28829660
[TBL] [Abstract][Full Text] [Related]
23. Favourable response to rituximab by an ocular adnexal primary lymphoma.
Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I
Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186
[TBL] [Abstract][Full Text] [Related]
24. Lacrimal sac lymphoproliferative lesion: case report.
Coloma-González I; Ruíz-García L; Ceriotto A; Corredor-Casas S; Salcedo-Casillas G
Arch Soc Esp Oftalmol; 2015 Mar; 90(3):144-7. PubMed ID: 25443184
[TBL] [Abstract][Full Text] [Related]
25. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease.
Hong JW; Kang S; Song MK; Ahn CJ; Sa HS
Br J Ophthalmol; 2018 Nov; 102(11):1591-1595. PubMed ID: 29420193
[TBL] [Abstract][Full Text] [Related]
26. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease.
Cheuk W; Yuen HK; Chan AC; Shih LY; Kuo TT; Ma MW; Lo YF; Chan WK; Chan JK
Am J Surg Pathol; 2008 Aug; 32(8):1159-67. PubMed ID: 18580683
[TBL] [Abstract][Full Text] [Related]
27. IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma.
Cheuk W; Lee KC; Chong LY; Yuen ST; Chan JK
Am J Surg Pathol; 2009 Nov; 33(11):1713-9. PubMed ID: 19701072
[TBL] [Abstract][Full Text] [Related]
28. Unique case of orbital 'progressive transformation of the germinal centre'-type immunoglobulin-G4 disease with a heralding lesion in the inguinal lymph nodes.
Patheja RS; Singh M; Bennett JA; Sullivan TJ
Clin Exp Ophthalmol; 2016; 44(1):65-7. PubMed ID: 26146857
[No Abstract] [Full Text] [Related]
29. Conjunctival Infiltration in a Child as a Rare Manifestation of IgG4-Related Disease.
Qi SR; Hébert M; You E; Proulx-Gauthier JP; Légaré ME
Cornea; 2022 Apr; 41(4):496-498. PubMed ID: 34050069
[TBL] [Abstract][Full Text] [Related]
30. Ocular adnexal reactive lymphoid hyperplasia in children.
Al-Mujaini A; Wali U; Ganesh A; Al-Hadabi I; Burney I
Middle East Afr J Ophthalmol; 2012 Oct; 19(4):406-9. PubMed ID: 23248544
[TBL] [Abstract][Full Text] [Related]
31. Intralesional Rituximab for the Treatment of Recurrent Ocular Adnexal Lymphoma.
Demirci H; Kauh CY; Rajaii F; Elner VM
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S70-S71. PubMed ID: 26950471
[TBL] [Abstract][Full Text] [Related]
32. Hepatic nodular lymphoid lesion with increased IgG4-positive plasma cells associated with primary biliary cirrhosis: a report of two cases.
Calvo J; Carbonell N; Scatton O; Marzac C; Ganne-Carrie N; Wendum D
Virchows Arch; 2015 Nov; 467(5):613-7. PubMed ID: 26358058
[TBL] [Abstract][Full Text] [Related]
33. Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review.
Matsuo T; Tanaka T; Notohara K; Okada K
J Investig Med High Impact Case Rep; 2022; 10():23247096211067894. PubMed ID: 35038946
[TBL] [Abstract][Full Text] [Related]
34. Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis.
Farmer JP; Lamba M; Lamba WR; Jordan DR; Gilberg S; Sengar DP; Bence-Bruckler I; Burns BF
Can J Ophthalmol; 2005 Apr; 40(2):151-60. PubMed ID: 16049528
[TBL] [Abstract][Full Text] [Related]
35. MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab.
Tektonidou MG
Lupus; 2010 Sep; 19(10):1243-5. PubMed ID: 20501524
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic criteria for IgG4-related ophthalmic disease.
Goto H; Takahira M; Azumi A;
Jpn J Ophthalmol; 2015 Jan; 59(1):1-7. PubMed ID: 25392273
[TBL] [Abstract][Full Text] [Related]
37. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD.
Andrew NH; Sladden N; Kearney DJ; Selva D
Br J Ophthalmol; 2015 Mar; 99(3):376-81. PubMed ID: 25185258
[TBL] [Abstract][Full Text] [Related]
38. The many facets of dacryoadenitis.
Mombaerts I
Curr Opin Ophthalmol; 2015 Jul; 26(5):399-407. PubMed ID: 26247137
[TBL] [Abstract][Full Text] [Related]
39. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy.
Wong PC; Fung AT; Gerrie AS; Moloney G; Maberley D; Rossman D; White V; Collins D; Coupland R; Chen LY
Eur J Haematol; 2013 Mar; 90(3):250-6. PubMed ID: 23278107
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement.
Matsuo T; Ichimura K; Sato Y; Tanimoto Y; Kiura K; Kanazawa S; Okada T; Yoshino T
J Clin Exp Hematop; 2010; 50(2):129-42. PubMed ID: 21123971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
